Does saturable formation of gemcitabine triphosphate occur in patients?
10.1007/s00280-008-0707-9
Saved in:
Main Authors: | Tham, L.-S., Wang, L.-Z., Soo, R.A., Lee, H.-S., Lee, S.-C., Goh, B.-C., Holford, N.H.G. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/105848 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014) -
A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2014) -
A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2011) -
Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
by: Limviphuvadh, Vachiranee, et al.
Published: (2018) -
Pharmacology of Gemcitabine in the Asian Population
by: WANG LINGZHI
Published: (2010)